These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 808578)

  • 41. The burden of Chagas disease: estimates and challenges.
    Stanaway JD; Roth G
    Glob Heart; 2015 Sep; 10(3):139-44. PubMed ID: 26407508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical study of Chagas' disease (trypanosomiasis cruzi).
    Older JJ
    South Med J; 1969 Jun; 62(6):729-33. PubMed ID: 4977708
    [No Abstract]   [Full Text] [Related]  

  • 43. [Visceral diseases in Chagas' disease and related concepts].
    Minoprio JL; Passardi H; Murua F
    Prensa Med Argent; 1969 May; 56(12):522-9. PubMed ID: 4981041
    [No Abstract]   [Full Text] [Related]  

  • 44. Suppression of antibody dependent cytotoxicity to Trypanosoma cruzi in chronic chagasic mice after treatment with nifurtimox.
    Chambó JG; Cabeza Meckert PM; Laguens RP
    Medicina (B Aires); 1988; 48(1):49-53. PubMed ID: 3146009
    [No Abstract]   [Full Text] [Related]  

  • 45. An unusual cause for massive inflation.
    Kelly ME; Courtney D; Heeney A; Allen M
    Ir Med J; 2015 May; 108(5):150-1. PubMed ID: 26062244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chagasic megaesophagus and megacolon diagnosed in childhood and probably caused by vertical transmission.
    Da-Costa-Pinto EA; Almeida EA; Figueiredo D; Bucaretchi F; Hessel G
    Rev Inst Med Trop Sao Paulo; 2001; 43(4):227-30. PubMed ID: 11558004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. American trypanosomiasis (Chagas' disease).
    Kirchhoff LV
    Gastroenterol Clin North Am; 1996 Sep; 25(3):517-33. PubMed ID: 8863038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.
    Urbina JA
    Acta Trop; 2010; 115(1-2):55-68. PubMed ID: 19900395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 50. Antitrypanosomal therapy for chronic Chagas' disease.
    Bern C
    N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 52. [Chagas's heart disease].
    MONTOREANO F; RABENKO J; ABRAHIM HC
    Rev Asoc Med Argent; 1960 Jul; 74():434-8. PubMed ID: 13772227
    [No Abstract]   [Full Text] [Related]  

  • 53. [Cardiopathia parasympathicopriva].
    KOEBERLE F
    Munch Med Wochenschr; 1959 Jul; 101():1308-10. PubMed ID: 14410379
    [No Abstract]   [Full Text] [Related]  

  • 54. [STUDIES OF WILD RESERVOIRS AND VECTORS OF TRYPANOSOMA CRUZI. IV. NATURAL INFECTION OF TRIATOMA INFESTANS, FOUND IN WILD FOREST ECOTOPES, CAUSED BY A TRYPANOSOME RESEMBLING T. CRUZI].
    BARRETTO MP; FERRIOLLIFILHO F
    Rev Inst Med Trop Sao Paulo; 1964; 6():219-24. PubMed ID: 14242006
    [No Abstract]   [Full Text] [Related]  

  • 55. Gastrointestinal aspects of Chagas' disease.
    Earlam RJ
    Am J Dig Dis; 1972 Jun; 17(6):559-71. PubMed ID: 4624133
    [No Abstract]   [Full Text] [Related]  

  • 56. [Megacolon and Chagas' disease. (Preliminary report)].
    ATIAS A; NEGHME A; AGUIRRE MAC-KAY L; HERRERA E
    Rev Med Chil; 1960 Feb; 88():94-7. PubMed ID: 13794950
    [No Abstract]   [Full Text] [Related]  

  • 57. The BENEFIT Trial: Where Do We Go from Here?
    Pecoul B; Batista C; Stobbaerts E; Ribeiro I; Vilasanjuan R; Gascon J; Pinazo MJ; Moriana S; Gold S; Pereiro A; Navarro M; Torrico F; Bottazzi ME; Hotez PJ
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004343. PubMed ID: 26913759
    [No Abstract]   [Full Text] [Related]  

  • 58. The structure-activity relationship of 4-(5'-nitrofurfurylidene-amino)-tetrahydro-4H-1,4-thiazine-1,1-dioxides active against Trypanosoma cruzi.
    Bock M; Haberkorn A; Herlinger H; Mayer KH; Petersen S
    Arzneimittelforschung; 1972 Sep; 22(9):1564-9. PubMed ID: 4630482
    [No Abstract]   [Full Text] [Related]  

  • 59. Predictors of development of cardiac and digestive disorders among patients with indeterminate chronic Chagas Disease.
    Nunes da Costa EAP; Victória C; Fortaleza CMCB
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009680. PubMed ID: 34388146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [FLUORESCENCE MICROSCOPY OF THE RAT HEART IN EXPERIMENTAL TRYPANOSOMA CRUZI INFECTION].
    MENEZES H; DE OLIVEIRA JS
    Rev Inst Med Trop Sao Paulo; 1964; 6():155-6. PubMed ID: 14187812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.